All In Biotech

Drug Trial Radar · NCT04863274

Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

The Program to Assess the Influence of Routing and In-depth Consultation of Patients With Cardiovascular Risk Factors on the Choice of Medicine and Treatment Compliance

Last checked: Nov 20, 2026Latest source record: May 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,912

Actual

Start

Jun 21, 2018

Primary completion

Oct 15, 2020

Study completion Oct 15, 2020

Sponsor

Lead sponsor
The League of Clinical Research, RussiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Research Center for Preventive Medicine
First posted
Apr 28, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases: * the retrospective part: database of patients with cardiovascular risks; * the prospective part: observation of patients in the real world medical practice.

Conditions

  • Lipid Metabolism Disorders

Interventions

  • atorvastatinDrug

    Profound patients' consultations (different from standard practice) on the importance of primary prevention of cardiovascular diseases, including preventive administration of statins. Subjects in profound consultation group will receive regular reminders (2 times a month) via SMS and phone calls to check following the doctor's recommendations and remind about follow-up visit to study centre.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target level of LDL cholesterolTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • League of Clinical Research (LeagueCRR)

    Moscow, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.